| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |